盐酸丙哌维林结构式
|
常用名 | 盐酸丙哌维林 | 英文名 | Propiverine hydrochloride |
---|---|---|---|---|
CAS号 | 54556-98-8 | 分子量 | 403.942 | |
密度 | N/A | 沸点 | 494.7ºC at 760 mmHg | |
分子式 | C23H30ClNO3 | 熔点 | 213-216ºC | |
MSDS | 中文版 美版 | 闪点 | 253ºC | |
符号 |
GHS05, GHS07 |
信号词 | Danger |
盐酸丙哌维林用途Propiverine hydrochloride 是具有钙拮抗和抗胆碱能特性的膀胱痉挛剂。Propiverine hydrochloride 可用于研究膀胱过度活动和尿失禁。 |
中文名 | 盐酸丙哌维林 |
---|---|
英文名 | Propiverine Hydrochloride |
中文别名 | 罗匹外宁 | 1-甲基-4-哌啶基二苯基丙氧乙酸酯盐酸盐 |
英文别名 | 更多 |
描述 | Propiverine hydrochloride 是具有钙拮抗和抗胆碱能特性的膀胱痉挛剂。Propiverine hydrochloride 可用于研究膀胱过度活动和尿失禁。 |
---|---|
相关类别 | |
体外研究 | 丙三嗪(10-3000nm)抑制[3H]NMS的特异性结合,小鼠膀胱、颌下腺和心脏的Kis分别为339、193和497nm[2]。 |
体内研究 | 丙肾上腺素(0.5毫克/天;每天一次,持续2周)在被动膀胱内压升高期间显著增加UBP和LPP,并增加大鼠血浆去甲肾上腺素和肾上腺素水平[1]。在体剂量为1mg/kg时,丙肾上腺素(0.01-1mg/kg;静脉注射)可降低UBP并完全抑制喷嚏反射[1]。动物模型:雌性成年Sprague-Dawley大鼠(250-270g)[1]剂量:5mg溶于蒸馏水(0.5ml)给药:P.o.每日1次,连续2周。结果:尿道基线压(UBP)和漏点压(LPP)显著升高。肾上腺素和肾上腺素水平升高。体重无明显变化。 |
参考文献 |
沸点 | 494.7ºC at 760 mmHg |
---|---|
熔点 | 213-216ºC |
分子式 | C23H30ClNO3 |
分子量 | 403.942 |
闪点 | 253ºC |
精确质量 | 403.191437 |
PSA | 38.77000 |
LogP | 4.73410 |
外观性状 | 白色晶体粉末 |
储存条件 | -20°C Freezer |
符号 |
GHS05, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H315-H318-H335 |
警示性声明 | P261-P280-P305 + P351 + P338 |
危害码 (欧洲) | Xi |
风险声明 (欧洲) | 37/38-41 |
安全声明 (欧洲) | 26-39 |
危险品运输编码 | NONH for all modes of transport |
RTECS号 | AH3297000 |
海关编码 | 2933399090 |
~% 盐酸丙哌维林 54556-98-8 |
文献:WO2011/114195 A1, ; Page/Page column 6-7 ; |
盐酸丙哌维林上游产品 1 | |
---|---|
盐酸丙哌维林下游产品 1 | |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Excitatory effect of propiverine hydrochloride on urethral activity in rats.
Int. J. Urol. 19(6) , 575-82, (2012) To investigate the effects of the antimuscarinic agent, propiverine, on the bladder and urethra in rats.A total of 54 female rats were given propiverine, imidafenacin (an antimuscarinic agent), or dis... |
|
[Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
Hinyokika Kiyo. 57(2) , 71-6, (2011) The efficacy and safety of additional administration of propiverine were prospectively studied for naftopidil-resistant nocturia in patients with benign prostatic hypertrophy (BPH). Patients of 50 yea... |
|
An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.
Urol. Int. 89(3) , 259-69, (2012) To provide an overview on the efficacy, tolerability, safety and health-related quality of life (HRQoL) of drugs with a mixed action used in the treatment of overactive bladder (OAB).MEDLINE database ... |
Mictonetten |
Mictonorm |
Propiverine hydrochloride |
Propiverine Hydrochlorride |
1-Methyl-4-piperidinyl diphenyl(propoxy)acetate hydrochloride (1:1) |
Propiverine HCl |
UNII-DC4GZD10H3 |
Benzeneacetic acid, α-phenyl-α-propoxy-, 1-methyl-4-piperidinyl ester, hydrochloride (1:1) |
1-Methylpiperidin-4-yl diphenyl(propoxy)acetate hydrochloride (1:1) |